Editas Medicine, Inc. (LON:0IFK)
London · Delayed Price · Currency is GBP · Price in USD 1.710
-0.030 (-1.72%)
Feb 12, 2026, 4:59 PM GMT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of 126.64 million as of February 12, 2026. Its market cap has increased by 34.35% in one year.
Market Cap
126.64M
Enterprise Value
19.63M
Revenue
34.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.71
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from 425.65M to 126.64M, a decrease of -70.25%. That is a compound annual growth rate of -11.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 126.64M | -14.83% |
| Dec 31, 2025 | 148.69M | 77.56% |
| Dec 31, 2024 | 83.74M | -87.11% |
| Dec 29, 2023 | 649.54M | 31.18% |
| Dec 30, 2022 | 495.14M | -62.67% |
| Dec 31, 2021 | 1.33B | -58.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Optima Health | 189.54M |
| Diaceutics | 142.24M |
| Scancell Holdings | 128.68M |
| Shield Therapeutics | 114.81M |